Anthera Pharmaceuticals, Inc. (ANTH) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:

Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Sowpon Hoque Sowpon Hoque 08/02/2016 3 months $3.03 $2.30 -24.09% -24 Ended
Comments: $25 target price
herman.hoorn herman.hoorn 05/18/2015 3 months $4.99 $9.22 +84.77% 84 Ended
Comments: yes
Biotech_Invest Biotech_Invest 10/08/2014 3 months $1.62 $2.27 +40.12% 40 Ended
Comments: starting 10/08/14 ANTH is STRONG BUY - Big Pharma will partner peptibodies for lupus and other apps
roiomax71 roiomax71 12/09/2013 1 Year $2.89 $1.99 -31.14% -31 Ended
Comments: the share is at a minimum with strong forecast upward
FrankieOrona FrankieOrona 07/03/2013 3 months $0.50 $3.17 +527.97% 527 Ended
Comments: Its pipe line will show good results really soon out of Phase 2, and is already at a all time low
Zatzak Zatzak 02/26/2013 3 months $0.62 $0.60 -3.23% -3 Ended
S_GREWAL S_GREWAL 07/12/2012 1 day $0.69 $0.70 +2.17% -2 Ended
Comments: Industry sector declining or poised for decline
B1capital B1capital 07/10/2012 3 months $0.74 $1.01 +36.12% 36 Ended
Comments: Industry sector growing or poised for growth
OMARI OMARI 05/14/2012 3 months $2.17 $0.92 -57.42% -57 Ended
Comments: Industry sector growing or poised for growth

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.